As of 2024-12-15, the Fair Value of Oncozenge AB (ONCOZ.ST) is -5.03 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.77 SEK, the upside of Oncozenge AB is -233.26%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -3.89 | -46.65 | -15.90 | - | -22.14 | |
| YoY growth | -511.01% | -1,100.36% | 65.91% | - | -515.15% | |
| Market Cap (mil) | 44.21 |
| P/E | |
| Forward P/E |
| EPS | -1.01 |
| Avg earnings growth rate | -515.15% |
| TTM earnings | -11.78 |